France· FR:66445061
HAIMA 1000 mg, granulés enrobés en sachet
A medicinal product containing acide tranexamique, registered in France by CEMAG CARE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACIDE TRANEXAMIQUE
- Manufacturer
- CEMAG CARE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093028156712 sachet(s) polyéthylène basse densité (PEBD) aluminium papier de 1750 mg
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acide tranexamique in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNexag 1000 mg, omhuld granulaat in sachetCemag Care
- BelgiumNimra 1000 mgCemag Care
- PolandHaixaCemag Care
- SwedenNexag 1 g Dragerat granulat i dospåseCemag Care
- United KingdomCyklo-f Heavy Period Relief 500mg tabletsThe Boots Company Plc
- United StatesCyklokapronPfizer Laboratories Div Pfizer Inc
- CzechiaEXACYLCHEPLAPHARM Arzneimittel GmbH, Greifswald
- SwitzerlandCyklokapron
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Cyklokapron, Tranexamsäure Baxter
- Belgium · Acide Tranexamique Kabi, Cyklokapron
- Bulgaria · Медокапрон, Т-Капрон
- Cyprus · Azeptil, Medsamic
- Czechia · Exacyl, Tranexamic Acid Accord
- Germany · Cyklokapron, Cyklokapron-Injektionslösung
- Denmark · Cyklokapron, Cyklonova
- Estonia · Cyklokapron, Medsamic
- Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
- Finland · Caprilon, Cyklokapron
- United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
- Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
- Croatia · Medsamic, Trenolk
- Hungary · Exacyl, Nimra
- Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
- Iceland · Cyklokapron, Tranexamsyre Pfizer
- Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
- Lithuania · Haixa, Tranexamic Acid Baxter
- Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
- Latvia · Cyklokapron, Haixa
- Malta · Azeptil, Medsamic
- Netherlands · Cyklokapron, Nexag
- Norway · Cyklokapron, Pilexam
- Poland · Deporium, Deporium Comfort
- Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
- Romania · Acid Tranexamic Kabi, Medsamic
- Sweden · Cyklo-F, Cyklokapron
- Slovenia · Medsamic, Trenolk
- Slovakia · Medsamic, Tranexamic Acid Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d6dc87c-fbd8-46d2-92c2-1be2e580e4e2 GET /v1/drugs/3d6dc87c-fbd8-46d2-92c2-1be2e580e4e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66445061",
"date_amm": "2023-11-09",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "ACIDE TRANEXAMIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "granulés enrobé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about acide tranexamique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.